CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRLNYSEIndustrials · Services-Commercial Physical & Biological Research · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B |
| Operating income | $25.2M | $227.3M | $617.3M | $651.0M | $589.9M | $432.7M |
| Net income | −$144.3M | $22.2M | $474.6M | $486.2M | $391.0M | $364.3M |
| Total assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B |
| Total liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B |
| Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B |
| EPS (diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 |
| Shares out. | 51.1M | 51.3M | 51.0M | 50.5M | 49.8M | 49.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 0.6%
- Net margin
- −3.6%
- Return on equity
- −4.6%
- Return on assets
- −2.0%
- Return on capital (ROCE)
- 0.4%
- Liabilities / assets
- 55.0%
- Debt / equity
- 1.24×
- Book value / share
- $61.88
- Revenue growth (YoY)
- −0.9%
- Net income growth (YoY)
- −750.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.81grey zone
- Accruals / assets
- −12.4%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 warning● 3 good- Reported a net loss
- Revenue declined year-over-year
- Altman Z″ in the grey zone
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Invesco Ltd.Passive (13G)May 6, 2026
- Fmr LlcPassive (13G)May 6, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Wellington Management Group LlpPassive (13G)Feb 10, 2026
- Nomura Holdings IncPassive (13G)Nov 14, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.6M | 3.8 | +8.5% |
| Apr 30, 2026 | 3.3M | 4.5 | -28.2% |
| Apr 15, 2026 | 4.7M | 5.4 | +1.6% |
| Mar 31, 2026 | 4.6M | 5.3 | +22.3% |
| Mar 13, 2026 | 3.8M | 4.0 | +6.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer change · Shareholder voteMay 11, 2026
- Results of operationsMay 7, 2026
- Regulation FD disclosureFeb 25, 2026
- Director / officer changeFeb 18, 2026
- Results of operationsFeb 18, 2026
- Results of operations · Regulation FD disclosureJan 13, 2026
- Director / officer changeJan 9, 2026
- Regulation FD disclosureDec 3, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 14, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 4PRIMARY DOCUMENTMay 12, 2026
- 8-KFORM 8-KMay 11, 2026
- 4PRIMARY DOCUMENTMay 11, 2026
- 4PRIMARY DOCUMENTMay 11, 2026
- 4PRIMARY DOCUMENTMay 11, 2026
- 4PRIMARY DOCUMENTMay 11, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.